tezosentan has been researched along with eniporide in 2 studies
| Studies (tezosentan) | Trials (tezosentan) | Recent Studies (post-2010) (tezosentan) | Studies (eniporide) | Trials (eniporide) | Recent Studies (post-2010) (eniporide) |
|---|---|---|---|---|---|
| 157 | 29 | 33 | 32 | 3 | 1 |
| Protein | Taxonomy | tezosentan (IC50) | eniporide (IC50) |
|---|---|---|---|
| Sodium/hydrogen exchanger 1 | Homo sapiens (human) | 0.1558 | |
| Sodium/hydrogen exchanger 1 | Oryctolagus cuniculus (rabbit) | 0.008 | |
| Sodium/hydrogen exchanger 3 | Oryctolagus cuniculus (rabbit) | 0.008 | |
| Sodium/hydrogen exchanger 2 | Oryctolagus cuniculus (rabbit) | 0.008 | |
| Sodium/hydrogen exchanger 2 | Homo sapiens (human) | 3.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Cleland, JG; Coletta, AP | 1 |
2 other study(ies) available for tezosentan and eniporide
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology--WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME.
Topics: Anticoagulants; Aspirin; Cardiovascular Diseases; Clinical Trials, Phase II as Topic; Electric Countershock; Europe; Guanidines; Humans; Pyridines; Randomized Controlled Trials as Topic; Sulfones; Tetrazoles; Vasodilator Agents; Warfarin | 2001 |